AI assistant
Sending…
AtriCure, Inc. — Director's Dealing 2017
Jan 4, 2017
31802_dirs_2017-01-04_2603255e-7073-45d5-ac26-c64d8dd1daa1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2016-12-30
Reporting Person: CARREL MICHAEL H (Director, President, CEO, & Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-12-30 | Common Stock | A | 556 | $12.27 | Acquired | 510084 | Direct |
Footnotes
F1: Shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ended December 30, 2016.
F2: Closing price on December 30, 2016 was $19.57.
More from AtriCure, Inc.
Regulatory Filings
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Interim / Quarterly Report
2026
May 6
Report Publication Announcement
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 6
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3